捷诺达-强强联合-卓越降糖.pptVIP

  • 9
  • 0
  • 约10.65万字
  • 约 55页
  • 2019-09-11 发布于浙江
  • 举报
Rationale for Combination Therapy Combination therapy may provide more glycemic control than the individual monotherapies. Combination therapy may provide more comprehensive coverage of the key pathophysiologies of type 2 diabetes than monotherapies. An appropriately chosen combination therapy may help more patients achieve their HbA1c goal without increasing side effects.1 Reference: 1. Del Prato S, Felton-A-M, Munro et al. Improving glucose management: Ten steps to get more patients with type 2 diabetes to glycaemic goal Int J Clin Pract 2005;59:1345-1355. Clinical Effects of Oral Antid

文档评论(0)

1亿VIP精品文档

相关文档